Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
32 33 Next >
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
Tickers BIIB JNJ MRNA OCGN
Tags MRNA JNJ Recent Press Releases
From Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
Tickers BIIB KSS NLSN
Tags Stocks to Sell NLSN Market News
From InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags Biotech Alzheimer's disease Benzinga
From Benzinga
2 Red Flags for Biogen's Future
Tickers BIIB LLY
Tags LLY Recent Press Releases Market News
From Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Briefs News Biotech
From Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
Tickers BIIB ESALF ESALY
Tags Market News General Contracts
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags SYRS EXEL GMDA
From Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
Tickers BIIB NVS RHHBY
Tags News Briefs Biotech
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Tickers ACET ACTD ALEC AREN
Tags SWN RVLV DTM
From Benzinga
10 Biggest Price Target Changes For Tuesday
Tickers AUPH AVDX BBBY BIIB
Tags WLL AUPH CARA
From Benzinga
As President Biden proposed, Medicare needs the ability to negotiate drug prices
Tickers BIIB
Tags BIIB
From MarketWatch
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
Tickers BIIB CEMI ESALY EYEN
Tags ESALY Benzinga Biotech
From Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
Tickers BIIB
Tags Market News Analyst Color BIIB
From Benzinga
Expert Ratings For Biogen
Tickers BIIB
Tags Analyst Ratings BIIB BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
Tickers ALGT AORT AVTX BALY
Tags Upgrades GRWG KRC
From Benzinga
10 Biggest Price Target Changes For Thursday
Tickers AEO AI BHG BIIB
Tags Industrials GMTX Pre/Market Outlook
From Benzinga
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver
Tickers BIIB PFE VTRS
Tags VTRS BIIB PFE
From MarketWatch
Medicare’s finances and the saga of the Alzheimer’s drug Aduhelm
Tickers BIIB
Tags BIIB
From MarketWatch
What Investors Can Learn From Biogen's Drug Approval That No One Wants
Tickers BIIB
Tags BIIB Market News Recent Press Releases
From Motley Fool
Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen?
Tickers BIIB
Tags Market News Recent Press Releases BIIB
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
Tickers AFRM AGNC AHI ALGS
Tags NXGL VITL ANGI
From Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
Tickers BIIB SAGE
Tags SAGE Market News BIIB
From Benzinga
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
Tickers BIIB BNTX PFE
Tags News Health Care BIIB
From Benzinga
3 Red Flags for Biogen's Future
Tickers BIIB
Tags BIIB Market News Recent Press Releases
From Motley Fool
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Tickers ALKS AMGN ATXI AVNS
Tags AZN GILD MRNA
From Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
Tickers ARVN BIIB CCCC GOOG
Tags VRTX GOOG Recent Press Releases
From Motley Fool
What to Expect From Biogen's $2.3 Billion Shopping Spree
Tickers AUPH BHVN BIIB GS
Tags AUPH BHVN Recent Press Releases
From Motley Fool
2 High-Yield Dividend Stocks That Are Trading Near Their 52-Week Lows
Tickers AMGN BIIB GILD MMM
Tags Recent Press Releases Market News GILD
From Motley Fool
2 Reasons to Buy Biogen, 1 Reason to Sell
Tickers BIIB
Tags Market News Recent Press Releases BIIB
From Motley Fool
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
Tickers BIIB UCBJF UCBJY
Tags UCBJY UCBJF Market News
From Benzinga
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.